Get started
Author

Kosuke Robert Shima

Observed names: K Shima, K. R. Shima, K. Shima, Kosuke R. Shima, Kosuke Shima, Shima, Kosuke
ORCID: 0000-0002-8523-6092
Observed ORCID: 0000-0002-8523-6092
OpenAlex ID: A5046403762
Proteasome Dysfunction Mediates Obesity-Induced Endoplasmic Reticulum Stress and Insulin Resistance in the Liver
2012 · Toshiki Otoda, Toshinari Takamura, et al. · Diabetes · 134
Clock gene expression in peripheral leucocytes of patients with type 2 diabetes
2008 · H. Ando, T. Takamura, et al. · Diabetologia · 125
PDF
Effect of Empagliflozin on Endothelial Function in Patients With Type 2 Diabetes and Cardiovascular Disease: Results from the Multicenter, Randomized, Placebo-Controlled, Double-Blind EMBLEM Trial
2019 · Atsushi Tanaka, Michio Shimabukuro, et al. · Diabetes Care · 61
Ursodeoxycholic acid potentiates dipeptidyl peptidase-4 inhibitor sitagliptin by enhancing glucagon-like peptide-1 secretion in patients with type 2 diabetes and chronic liver disease: a pilot randomized controlled and add-on study
2018 · Kosuke Robert Shima, Tsuguhito Ota, et al. · BMJ Open Diabetes Research & Care · 47
PDF
Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial
2017 · Atsushi Tanaka, Michio Shimabukuro, et al. · Cardiovascular Diabetology · 32
PDF
Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo‐controlled double‐blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi‐center placebo‐controlled double‐blind randomized trial
2020 · Atsushi Tanaka, Michio Shimabukuro, et al. · Journal of Diabetes Investigation · 26
The hepatic circadian clock is preserved in a lipid-induced mouse model of non-alcoholic steatohepatitis
2009 · Hitoshi Ando, Toshinari Takamura, et al. · Biochemical and Biophysical Research Communications · 26
Heterogeneous nature of diabetes in a family with a gain-of-function mutation in the ATP-binding cassette subfamily C member 8 (ABCC8) gene
2018 · Kosuke Robert Shima, Rika Usuda, et al. · Endocrine Journal · 14
PDF
Impact of preoperative pasireotide therapy on invasive octreotide-resistant acromegaly
2018 · Reina Yamamoto, Kosuke Robert Shima, et al. · Endocrine Journal · 12
PDF
Blood pressure reduction with empagliflozin in Japanese patients with type 2 diabetes and cardiovascular diseases: a post-hoc sub-analysis of the placebo-controlled randomized EMBLEM trial
2024 · Atsushi Tanaka, Michio Shimabukuro, et al. · Hypertension Research · 8
A novel PHEX mutation associated with vitamin D-resistant rickets
2019 · Saori Sako, Yo Niida, et al. · Human Genome Variation · 8
PDF
Somatostatin Receptor-negative and Fluorodeoxyglucose-positron Emission Tomography-positive Lung Neuroendocrine Tumor G1 Exhibiting Cyclic Cushing's Syndrome
2022 · Chiaki Nomura, Yujiro Nakano, et al. · Internal Medicine · 5
PDF
Report of the committee of Japan Diabetes Society on the classification and diagnostic criteria of diabetes mellitus particularly higher risk to develop diabetes Diabetes-specific microvascular complications are rare but arteriosclerotic complications are fairly frequent in this category Gestational diabetes mellitus The current definition of GDM is any glucose intolerance developed or detected during pregnancy We adopt the proposal of the Japan Society of Gynecology and Obste
1999 · Takeshi Kuzuya, Shigeki Nakagawa, et al. · Tōnyōbyō/Tounyoubyou · 5
Overt Diabetes Mellitus Caused by the Topical Administration of Dexamethasone Ointment on the Oral Mucosa
2014 · Toshio Kahara, Yuri Tanaka, et al. · Internal Medicine · 4
PDF
Autoimmune Polyglandular Syndrome Type 3 with Anorexia
2012 · Toshio Kahara, Hitomi Wakakuri, et al. · Case Reports in Endocrinology · 4
PDF
Release of Gut GLI by Luminal Hypotonicity
1981 · T. Matsuyama, M. Namba, et al. · Hormone and Metabolic Research · 4
Mediastinal Thyroid Goiter with No Accumulation on Scintigraphy
2013 · Toshio Kahara, Tomomi Ichikawa, et al. · Internal Medicine · 3
PDF
[Diabetogenes; which cause type II diabetes mellitus].
1995 · T Murakami, K Shima · PubMed · 2
Exploration of factors associated with eGFR slope improvement before and after intensive treatment of patients with diabetic nephropathy at high risk of disease progression: a retrospective cohort study
2026 · Mayumi Kiku, Saori Sako, et al. · Journal of Rural Medicine
PDF
MOESM3 of Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial
2017 · Tanaka, Atsushi, Shimabukuro, Michio, et al. · Figshare
MOESM1 of Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial
2017 · Tanaka, Atsushi, Shimabukuro, Michio, et al. · Figshare
MOESM2 of Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial
2017 · Tanaka, Atsushi, Shimabukuro, Michio, et al. · Figshare
MOESM4 of Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial
2017 · Tanaka, Atsushi, Shimabukuro, Michio, et al. · Figshare
Comparison of acarbose versus voglibose monotherapy on GLP-1 secretion and postprandial dyslipidemia in patients with type 2 diabetes
2016 · Kosuke Shima, Rika Usuda, et al. · Diabetes Research and Clinical Practice
Diabetes mellitus in the elderly
1983 · H. Orimo, K. Doi, et al. · Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics
Works count: 26
Citation count: 520
H-index: 9
I10-index: 9
Year
Topic
Type